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The presence and pattern of iron accumulation in subcortical vascular mild cognitive
impairment (svMCI) and their effects on cognition have rarely been investigated. We
aimed to examine brain iron deposition in svMCI subjects using quantitative susceptibility
mapping (QSM). Moreover, we aimed to investigate the correlation between brain iron
deposition and the severity of cognitive impairment as indicated by z-scores. We
recruited 20 subcortical ischemic vascular disease (SIVD) patients who fulfilled the
criteria for svMCI. The control group comprised 19 SIVD patients without cognitive
impairment. The SIVD and control groups were matched based on age, gender,
and years of education. Both groups underwent QSM using a 3.0T MRI system.
Susceptibility maps were reconstructed from in vivo data, which were acquired with
a three-dimensional spoiled gradient recalled sequence. Then, regions of interest were
drawn manually on the map of each subject. The inter-group differences of susceptibility
values were explored in deep gray matter nuclei, including the bilateral pulvinar nucleus
of the thalamus, head of caudate nucleus, globus pallidus, putamen, hippocampus,
substantia nigra, and red nucleus. The correlations between regional iron deposition and
composite z-score, memory z-score, language z-score, attention-executive z-score and
visuospatial z-score were assessed using partial correlation analysis, with patient age
and gender as covariates. Compared with the control, the svMCI group had elevated
susceptibility values within the bilateral hippocampus and right putamen. Furthermore,
the susceptibility value in the right hippocampus was negatively correlated with memory
z-score and positively correlated with language z-score. The susceptibility value in the
right putamen was negatively correlated with attention-executive z-score in the svMCI
group. However, composite z-score were unrelated to susceptibility values. Our results
suggest that brain iron deposition has clinical relevance as a biomarker for cognition.
In addition, our results highlight the importance of iron deposition in understanding
svMCI-associated cognitive deficits in addition to conventional MRI markers.
Keywords: subcortical ischemic vascular disease, subcortical vascular mild cognitive impairment, quantitative
susceptibility mapping, iron deposition, gray matter nuclei
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INTRODUCTION
Vascular dementia (VaD) is clinically characterized by stepwise
progression, fluctuating course, and predominant deterioration
of intelligence with the relative preservation of personality.
VaD is the second most common form of dementia after
Alzheimer’s disease (AD) and places an enormous burden
on society (Erkinjuntti, 1999). In China, it is estimated that
the crude incidence in persons ≥65 years was 3.1/1000
person-years for VaD (Yuan et al., 2016). Subcortical vascular
dementia (SVaD), a small vessel disease (SVD), constitutes
approximately half of VaD cases (Yoshitake et al., 1995).
Recently, most studies have involved patients in the prodromal
stage of AD, referred to as the amnestic mild cognitive
impairment (aMCI). It is also clinically important to focus
on subcortical vascular mild cognitive impairment (svMCI),
which is a prodromal stage of SVaD and distinctive from
aMCI (Lee et al., 2014), since management of risk factors
and drug treatment could prevent the evolution of svMCI
to SVaD (Seo et al., 2010). Finding potential biomarkers for
early diagnosis and relating these biomarkers to cognitive
measurements before the onset of clinical deterioration are
urgent matters.
Patients with svMCI have been shown to exhibit cognitive
impairments in executive, language, visuospatial, and memory
functions (Seo et al., 2009, 2010) and have been associated
with structural and functional alterations in widespread
regions (Seo et al., 2010; Yi et al., 2012, 2015; Yoon et al.,
2013; Kim et al., 2014), while these functions are further
impaired in cases of SVaD (Kim et al., 2014). In svMCI
patients, subcortical areas, such as the basal ganglia and
thalamus, are more prominently involved than the frontal
region. Functional changes in the very early stages of svMCI
or SVaD likely begin in subcortical structures and may
progress to the frontal cortices in the later stages of the
disease (Seo et al., 2009). Structurally, specific pattern in
hippocampal atrophy progressed has been reported in patients
with svMCI, exhibiting focal atrophy in the lateral body,
while additional atrophy in the lateral head and inferior
body in SVaD patients (Kim et al., 2014). The region-specific
vulnerability of hippocampal subfields to svMCI pathology
has also been observed in the left subiculum/presubiculum
and in the right cornu ammonis4/dentate gyrus (Li et al.,
2016). Previous PET studies showed that hypometabolism
in the deep structures and frontal region of the brain is a
sensitive marker for SVaD. It could reflect disconnection from
the basal ganglia/thalamus as well as among cortical regions,
according to the concept of diastasis (Kerrouche et al., 2006).
A susceptibility weighted imaging (SWI) study demonstrated
that the severity of cognitive impairment is closely correlated
with widespread abnormal iron deposition in the hippocampus,
caudate nucleus, putamen, globus pallidus, substantia nigra,
hippocampus, and caudate nucleus of SVaD patients (Liu et al.,
2015a). These results implicate deep-structure areas in the
pathophysiological mechanism of the evolution of svMCI to
SVaD.
With the development of quantitative MRI techniques,
assessment of iron levels has become more accurate and
sensitive. Although SWI can takes advantage of the magnetic
property properties to of create useful image contrasts, but
it does not provide quantitative measures of magnetic
susceptibility. This limitation addressed by quantitative
susceptibility mapping (QSM), an MR technique that depicts and
quantifies magnetic susceptibility sources. QSM computes the
underlying susceptibility of each voxel as a scalar quantity (Liu
et al., 2015b). The voxel intensity reflects tissue susceptibility
to enable the quantitative investigation of iron concentration
in the brain regions where iron is the dominant source of
magnetic susceptibility (Bilgic et al., 2012; Langkammer
et al., 2012; Li et al., 2015a). In addition, the phase or T2∗
contrast a weighted summation of the magnetic properties
of the surrounding tissue, reflects only the “shadow” of the
surrounding susceptibility sources. QSM can provide an accurate
definition of the distribution of magnetic biomaterials in
MRI through deconvolution (Wang and Liu, 2015). More
importantly, magnetic susceptibility is a direct reflection of
the molecular composition and cellular architecture of the
tissue. Consequently, QSM is becoming a quantitative imaging
approach for characterizing normal and pathological tissue
properties by quantifying magnetic susceptibility (Liu et al.,
2015c). Therefore, QSM is being evaluated in a growing
number of clinical applications, including: (1) the separation
of diamagnetic calcium from paramagnetic iron; (2) the
quantification of myelination in the white matter; and (3) the
quantification of iron deposition and blood by-products (Liu
et al., 2015c). In recent studies, QSM has become increasingly
prominent in the search for a quantitative biomarker for
assessing the iron deposition. The spread of accumulated
iron accumulation in the brain spreading across the cortex,
cerebellum, and deep-brain nuclei was is age-correlated and
occurs throughout the adult lifespan (Acosta-Cabronero et al.,
2016). This is consistent with decay in the course of normal
brain aging. Therefore, in vivo QSM is a useful non-invasive
tool for investigating cerebral iron accumulation. Rapid iron
accumulation in subcortical and deep structures is also an
important developmental processes that contribute to cognitive
functions (Darki et al., 2016). Thus, QSM can be used in
future studies of predictive value for cognitive performance.
Additionally, movement and neurodegenerative disorders, such
as Parkinson’s disease (PD), VaD, and AD, are associated with
iron overload in the brain (Acosta-Cabronero et al., 2013; He
et al., 2015; Moon et al., 2016). Although it is unclear whether
iron accumulation is the cause or consequence of these diseases,
monitoring the spatial distribution and the temporal dynamics of
iron deposition may offer important insights on the pathogenesis
of these diseases. QSM can explain results in molecular terms
and identify elevated iron levels to assist early disease diagnosis
(Acosta-Cabronero et al., 2013; He et al., 2015). It has been
proved that SVaD contributes to the process of increased iron
accumulation in a SWI study (Liu et al., 2015a). Thus, iron
accumulation should also be detected in svMCI. However, it is
unknown whether brain iron concentrations in svMCI patients
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TABLE 1 | Exclusion criteria for SIVD and inclusion criteria for svMCI.
Exclusion criteria for SIVD
• Cortical and/or cortico–subcortical non-lacunar infarcts
• Watershed infarcts
• White-matter lesions of specific causes
• Neurodegenerative diseases (e.g., Alzheimer’s disease and Parkinson’s
disease)
• Intracerebral hemorrhages
• Normal-pressure hydrocephalus
• Alcoholic encephalopathy or illicit drug use
• Patients with major depression (Hamilton Depression Rating Scale
[HDRS] ≥ 18 (Hamilton, 1960), other psychiatric comorbidities or severe
cognitive impairments
• MRI safety contraindications and claustrophobia
• Education < 6 years
Inclusion criteria for svMCI
• Subjective cognitive complaints reported by the participant or caregiver
• Basically normal activities of daily living (ADL)
• Quantifiable cognitive impairment within 1 or more domains (memory,
attention-executive function, language or visuospatial function)
• No dementia
SIVD, subcortical ischemic vascular disease; svMCI, subcortical vascular mild
cognitive impairment.
distinctly change compared with those in controls without
cognitive impairment.
MATERIALS AND METHODS
Subjects
Thirty-nine subcortical ischemic vascular disease (SIVD) subjects
were recruited from patients who were admitted to the Neurology
Department of Ren Ji Hospital from February 2015 to December
2015. Patients were evaluated by clinical interview, neurologic
and neuropsychological tests, and brain MRI. In accordance
with the criteria suggested by Galluzzi et al. (2005), SIVD was
defined as subcortical white matter hyperintensities (WMHs) that
are visible on T2-weighted imaging with at least one lacunar
infarct. The exclusion criteria (Table 1) were applied as previously
described (Sun et al., 2011, 2016). Patients were excluded if
they presented with calcification or microbleeds in deep gray
matter nuclei, including the bilateral pulvinar nucleus of the
thalamus, head of caudate nucleus, globus pallidus, putamen,
hippocampus, substantia nigra, and red nucleus with dark spots
and negative susceptibility. Twenty patients with SIVD fulfilled
the svMCI criteria suggested by Petersen et al. (1999) and by
a recent study (Lee et al., 2014). The inclusion criteria are
presented in Table 1. The control group comprised 19 SIVD
patients with neuropsychological test scores within the normal
range. Members of the control group were matched based on age,
gender composition, and years in education. All the patients were
right-handed.
The objective of the present study is to investigate iron
deposition in the deep gray matter nuclei of svMCI patients and
its correlation with the severity of cognitive impairment. We
TABLE 2 | Comprehensive battery of neuropsychological tests used to
evaluate cognitive status.
Cognitive function Tests
Attention-executive function Chinese modified version of the Trail
Making Test (TMT)
Modified version of the Stroop
Color-Word Test (SCWT)
Category Verbal Fluency Test (VFT)
Memory function Chinese version of the Auditory Verbal
Learning Test (AVLT) for short-delay and
long-delay free recall
Rey–Osterrieth Complex Figure (ROCF)
delayed recall test (Chinese version)
Language function Boson Naming Test (the 30-item
version) to evaluate
Visuospatial function ROCF copy test
utilize QSM to achieve this objective in the hopes of establishing
a promising neuroimaging biomarker for the early diagnosis of
svMCI.
The current study was approved by the Research Ethics
Committee of the Ren Ji Hospital, School of Medicine, Shanghai
Jiao Tong University. Written informed consent was obtained
from each subject before participation. All procedures were in
accordance with the institutional guidelines.
Neuropsychological Tests
Neuropsychological assessments were completed by two
experienced neurologists (QX and WC) within 1 week after
MRI examination. No patients suffered transient ischemic
attack or a stroke between the MRI examination and the
assessment. All patients underwent a comprehensive battery of
neuropsychological tests, including tests of all cognitive domains.
The scales listed in Table 2 were used as described in a previous
study (Hachinski et al., 2006; Xu et al., 2014). The neurological
features of each patient in the svMCI group are presented in
Table 3.
The z-score is a standard score. Raw scores are transformed
into standard scores to facilitate interpretation. A z-score has
a mean of zero and a standard deviation of one (Iverson,
2011). It provides a simple measure for the comparison of
neuropsychological measures in terms of their deviation from the
mean. In this study, the raw scores of each neuropsychological
test were processed with z-transform. The z-scores of the
respective test were averaged. Then, composite z-score were
computed by averaging the z-scores of individual cognitive
domains.
MRI Data Acquisition
MRI scanning was conducted using a 3.0T MR system (Signa
HDxt; GE HealthCare, Milwaukee, WI, USA) equipped with
an eight-channel phased array head coil at Ren Ji Hospital.
Foam padding was used to restrict the head motion of each
patient. Earplugs were provided to reduce scanner noise.
Phase images with whole-brain coverage were acquired using a
standard flow-compensated three-dimensional spoiled gradient
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TABLE 3 | The neurological features of each individual svMCI patient.
Att-exe Memory Language Visuospatial
svMCI01 − + − −
svMCI02 − + − −
svMCI03 − + − −
svMCI04 − + − −
svMCI05 − + − −
svMCI06 + + − −
svMCI07 + + − −
svMCI08 + + − −
svMCI09 + + + −
svMCI10 − − + −
svMCI11 + + + −
svMCI12 + + − −
svMCI13 − + − −
svMCI14 − + − −
svMCI15 + + − −
svMCI16 − + − −
svMCI17 − + + −
svMCI18 + + + −
svMCI19 − + − −
svMCI20 + − − −
svMCI, subcortical vascular mild cognitive impairment; Att-exe, attention-executive
function; Memory, memory function; Language, language function; Visuospatial,
visuospatial function.
recalled (3D-SPGR) sequence with the following parameters:
TE1/1TE/TE16 = 3.2/2.42/39.5 ms, TR = 42.5 ms, FA = 12◦,
bandwidth = 62.5 kHz, FOV = 220 mm × 220 mm,
matrix = 256 × 256, slices = 66. This protocol resulted in
an isotropic in-plane resolution (0.86 mm × 0.86 mm) with a
slice thickness of 2 mm. The total acquisition time was about
4 min 27 s.
In addition to QSM images, following acquisitions were also
performed to confirm the other absence of structural lesions:
(1) 3D-SPGR sequence images (TR = 6.1 ms, TE = 2.8 ms,
TI = 450 ms, FA = 15◦, slice thickness = 1.0 mm, gap = 0,
FOV = 256 mm × 256 mm, and slices = 166); (2) T2-
fluid attenuated inversion recovery sequence (TE = 150 ms,
TR = 9075 ms, TI = 2250 ms, FOV = 256 mm × 256 mm,
and slices = 66); (3) axial T2-weighted fast spin-echo sequences
(TR = 3013 ms, TE = 80 ms, FOV = 256 mm × 256 mm, and
slices= 34).
Image Reconstruction
Before QSM reconstruction, the quality of the magnitude raw
data was checked by two trained observers. The images were
computed using a MATLAB-based software, called “STI Suite”
(Li et al., 2014). The tool freely available at http://people.duke.
edu/~cl160/ for non-commercial academic use. The method was
performed as suggested in previous studies (Li et al., 2011; He
et al., 2015). First, the image was reconstructed with 3D Fast
Fourier transform using complex k-space data for each of the
eight receiver coils and then separated into the magnitude and
phase images. The magnitude image was obtained from the
squared summation of the eight magnitude images. It was used
for the extraction of the brain tissue. The Fourier transform of
phase image for each individual coil was calculated from the
original wrapped phase data. Then, the resultant phase Fourier
transforms were averaged to yield the Fourier transform of the
final combined signal phase. In the next step, the background
phases were removed using the spherical mean value method
with a filter radius of 8 pixels. All voxels contained in the
sphere must be valid, which cannot be met at brain boundaries.
Therefore, the filter radius was gradually reduced to the largest
size possible at brain boundaries. Since the sphere size is finite,
the phase generated by the brain tissue outside the sphere is
harmonic in the sphere, and thus can also be removed along with
the background phase. This removed low frequency phase from
the brain tissue can be restored with a deconvolution operation
(Li et al., 2011; Schweser et al., 2011). The frequency map was
calculated from the resultant local phase image. In the final step,
quantitative susceptibility map was calculated from the frequency
map using an improved least-squares (iLSQR) method (Li et al.,
2015b). The regularization threshold for Laplace filtering was set
at 0.04 (He et al., 2015). Figure 1 shows the reconstructed QSM
images from a 58-year-old svMCI subject.
Region of Interest Analysis
The QSM method has been successfully applied to detect
the susceptibility values directly used for comparison without
reference to any selected structures (Li et al., 2015a). Then,
we selected iron-rich subcortical nuclei as regions of interest
(ROI) to assess the association between the susceptibility values
of these ROIs with cognitive performance. ROIs were selected
in accordance with previous studies and included the pulvinar
nucleus of the thalamus, head of caudate nucleus, globus
pallidus, putamen, hippocampus, substantia nigra, and red
nucleus (Liu et al., 2015a; Moon et al., 2016). Figure 2 presents
examples of the seven ROIs. The ROI were drawn manually
on the susceptibility maps using MRIcro software available
at http://www.mccauslandcenter.sc.edu/crnl/tools. Two trained
neuroradiologists (YS and YW), who were blinded to the clinical
data of the subjects, independently analyzed the MRI data.
Statistical Analyses
All statistical analyses were performed using SPSS (v. 17.0; SPSS
Inc., Chicago, IL, USA). To determine intergroup differences, the
age, education, and z-scores of the svMCI and control groups
were compared using an independent two-sample t-test. Gender
heterogeneity between groups was assessed using the Chi-square
test. Susceptibility values of the svMCI and control groups were
compared using two-sample t-tests. For data that were not
normally distributed, continuous variables were compared using
the Mann–Whitney U test. The significance levels were set at
p < 0.05 for all analyses. To assess the reliability of measurement
in segmenting ROI, we selected the MR images of 10 normal
subjects in accordance with a previous study (Moon et al.,
2016). Another rater independently measured the ROIs for each
anatomical target. Inter-rater reliability among all regions was
0.947 (95% confidence interval: 0.927–0.962, p< 0.001).
To identify the brain iron deposition in svMCI subjects
correlating with the severity of cognitive impairment according
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FIGURE 1 | A typical quantitative susceptibility maps with a 58-year-old subcortical vascular mild cognitive impairment subject.
FIGURE 2 | A typical susceptibility map from one single patient with svMCI illustrates the regions of interest. Colors represent areas of the brain:
red = head of caudate nucleus; green = putamen; yellow = globus pallidus; orange = pulvinar nucleus of the thalamus; dark blue = substantia nigra; pink = red
nucleus; light blue = hippocampus.
to the z-score, the correlations the susceptibility values of each
brain region showed group deference and the composite z-score,
memory z-score, language z-score, attention-executive z-score
and visuospatial z-score were assessed partial using correlation
analysis, with patient age and gender as covariates (Persson et al.,
2015).
RESULTS
Demographics, Neuropsychological
Scores, and MRI Data Analysis
Demographic characteristics and main neuropsychological
information are shown in Table 4. No significant differences in
age, gender, and education were found between the two groups.
The svMCI group had significantly lower composite z-score,
attention-executive z-score, memory z-score and language
z-score. The svMCI patients and control groups displayed no
difference in terms of visuospatial z-score.
Susceptibility Values of QSM Imaging
between Groups
The susceptibility values of the two groups are summarized
in Figure 3 and Table 5. The overall susceptibility value of
the svMCI group was higher than that of control subjects,
except for the right global pallidus. A significant difference in
susceptibility values was found in bilateral hippocampus and
TABLE 4 | Demographic, z-sores for svMCI group and control.
svMCI
(n = 20)
Control
(n = 19)
p-value
Age (year) 63.40 ± 7.98 65.11 ± 3.71 0.396
Gender (male/female) 13/3 15/4 0.622
Education(year) 10.70 ± 3.48 12.00 ± 2.56 0.194
Composite −0.50 ± 0.51 0.30 ± 0.45 <0.001
Att-exe −0.79 ± 0.82 0.18 ± 0.48 <0.001
Memory −1.69 ± 0.54 −0.21 ± 0.76 <0.001
Language −0.59 ± 1.31 0.38 ± 0.90 0.011
Visuospatial 1.07 ± 0.45 0.86 ± 0.87 0.365
svMCI, subcortical vascular mild cognitive impairment; Composite, composite
z-score; Att-exe, attention-executive z-score; Memory, memory z-score; Language,
language z-score; Visuospatial, visuospatial z-score.
Dates are given in means ± standard deviations; p-value < 0.05 was considered
to be statistically significant (Highlighted in Bold).
right putamen in svMCI group compared with control group
(right hippocampus: 0.052 ± 0.017, 0.038 ± 0.014, p < 0.01;
left hippocampus: 0.052 ± 0.018, 0.038 ± 0.012, p < 0.01; right
putamen: 0.074± 0.016, 0.061± 0.017, p< 0.05).
Correlation between Regional
Susceptibility Values and Z-Scores
In svMCI group, significantly negative correlations were
observed between the susceptibility value of right hippocampus
and memory z-score (r = −0.577, p = 0.012). The susceptibility
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FIGURE 3 | Comparison of the susceptibility values in svMCI group and the controls. Significant differences between svMCI group and controls are
represented as ∗p < 0.05. svMCI, subcortical vascular mild cognitive impairment; PULV, pulvinar nucleus of the thalamus; CN, head of caudate nucleus; GP, globus
pallidus; PUT, putamen; HP, hippocampus; SN, substantia nigra; RN, red nucleus.
TABLE 5 | Regional quantitative susceptibility mapping values for the
svMCI group and control group.
Susceptibility (ppm)
svMCI Control p-
value
Pulvinar nucleus of
the thalamus
Right 0.053 ± 0.020 0.049 ± 0.015 0.469
Left 0.053 ± 0.017 0.044 ± 0.015 0.120
Head of caudate
nucleus
Right 0.048 ± 0.010 0.046 ± 0.012 0.553
Left 0.047 ± 0.010 0.045 ± 0.014 0.494
Globus pallidus Right 0.128 ± 0.028 0.131 ± 0.026 0.788
Left 0.125 ± 0.030 0.123 ± 0.022 0.783
Putamen Right 0.074 ± 0.016 0.061 ± 0.017 0.024
Left 0.072 ± 0.015 0.071 ± 0.025 0.805
Hippocampus Right 0.052 ± 0.017 0.038 ± 0.014 0.010
Left 0.052 ± 0.018 0.038 ± 0.012 0.010
Substantia nigra Right 0.100 ± 0.019 0.096 ± 0.019 0.522
Left 0.097 ± 0.024 0.098 ± 0.021 0.907
Red nucleus Right 0.106 ± 0.022 0.096 ± 0.025 0.221
Left 0.107 ± 0.022 0.100 ± 0.021 0.270
svMCI, subcortical vascular mild cognitive impairment. Dates are given in
means ± standard deviations; p-value < 0.05 was considered to be statistically
significant (Highlighted in Bold).
value of the right hippocampus was positively correlated with the
language z-score (r = 0.523, p = 0.026). The susceptibility value
in the right putamen was negatively correlated with attention-
executive z-score in the svMCI group (r = −0.505, p = 0.033).
However, the composite z-score was not related to susceptibility
values (shown in Figure 4 and Table 6).
DISCUSSION
In the present study, the QSM technique was used to estimate the
possible alterations in iron accumulation in the brains of svMCI
subjects. Here, we observed that the svMCI group had higher iron
concentrations in most subcortical nuclei than the control group.
Iron was mainly deposited in the bilateral hippocampus and right
putamen of the svMCI group. Furthermore, the susceptibility
value in the right putamen and attention-executive z-score of
the svMCI group were inversely related. We also found that
the susceptibility value in the right hippocampus was negatively
correlated with memory z-score and positively correlated with
language z-score. However, composite z-score were not related
to iron accumulation in the svMCI group. These observed group
differences and clinical relevance of susceptibility value provide
important implications for svMCI-related mechanisms, which
could be detected by QSM.
Protein-associated iron is involved in many fundamental
biological processes in the brain, such as oxidative
phosphorylation, oxygen transportation, myelin production,
and neurotransmitter synthesis and metabolism (Ward et al.,
2014). However, excess iron may induce oxidative stress injury to
propagate tissue damage and neurodegeneration (Rouault, 2001;
Hametner et al., 2013). Neurodegeneration may result from
iron-induced apoptosis and ferroptosis, an iron-specific form
of non-apoptotic cell death (Ott et al., 2007; Dixon et al., 2012;
Ward et al., 2014). Iron deposits and ferritin concentrations
in the microglia and astrocytes of the cortex, basal ganglia,
amygdala, hippocampus, and cerebellum generally increase with
age. Iron deposition in specific brain regions is associated with
motor and cognitive impairment (Ward et al., 2014). In our
study, the age distributions of the svMCI and control groups
were similar to eliminate age-associated effects. Changes in iron
homoeostasis alter cellular iron distribution and accumulation in
neurodegenerative diseases (Bartzokis et al., 2000; Collingwood
and Dobson, 2006; Ward et al., 2014). Then, elevated iron levels
may catalyze free-radical mediated damage to exacerbate the
neurodegenerative stage (Filomeni et al., 2012). Traditionally,
however, SVD is different from neurodegenerative diseases
because it is induced by subcortical lesions and the incomplete
infarction of white matter. We found that iron deposition
in the hippocampus and putamen may be a biomarker of
svMCI. Moreover, iron deposition in these regions has a
similar accumulation pattern to those of AD or VD (Zhu et al.,
2009; Raven et al., 2013; Moon et al., 2016). Therefore, these
accumulation patterns occur not only in AD or VD, but also in
svMCI patients. svMCI or other forms of SVD also contribute to
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FIGURE 4 | Scatter plot illustrating the relationship between (A) susceptibility values in right hippocampus and memory z-score, (B) susceptibility values in
right hippocampus and language z-score, (C) susceptibility values in right putamen and attention-executive z-score.
TABLE 6 | Correlations of susceptibility values within bilateral
hippocampus and right putamen in svMCI group.
Right Left Right
hippocampus hippocampus putamen
Composite p-value 0.700 0.240 0.238
r-value 0.098 −0.292 −0.293
Att-exe p-value 0.821 0.564 0.033
r-value −0.057 −0.146 −0.505
Memory p-value 0.012 0.630 0.925
r-value −0.577 −0.122 0.024
Language p-value 0.026 0.626 0.994
r-value 0.523 −0.123 0.002
Visuospatial p-value 0.487 0.065 0.054
r-value −0.175 −0.443 −0.462
svMCI, subcortical vascular mild cognitive impairment; Composite, composite
z-score; Att-exe, attention-executive z-score; Memory, memory z-score; Language,
language z-score; Visuospatial, visuospatial z-score. p-value < 0.05 was
considered to be statistically significant (Highlighted in Bold).
increased iron accumulation in the deep brain nuclei and basal
ganglia (Liem et al., 2012; Liu et al., 2015a).
Whether the iron accumulation noted in svMCI is a secondary
effect or a primary event is not yet fully elucidated. Iron
accumulation might be a result of svMCI. The atrophy of the
cerebral cortex and the demyelination of white matter can
decrease iron demand from storage areas in the deep gray nuclei,
thus causing chronic iron accumulation (Dietrich and Bradley,
1988; Liem et al., 2012). Alternatively, iron deposition could
also cause svMCI given that abnormal iron deposition causes
white-matter disruption and atrophy (Ling et al., 2011). Iron
is implicated in the pathogenesis of WMHs given that iron
concentrations in the basal ganglia affect the severity of WMHs
(Yan et al., 2013). However, other studies have suggested that iron
accumulation is closely associated with the formation of cerebral
microbleeds, but not with WMHs in SVD (Gattringer et al., 2016;
Liu et al., 2016). Therefore, the precise mechanisms of higher iron
concentration in svMCI still remain unclear and require further
research.
We expect QSM to have a crucial quantitative role in
establishing the mechanisms involved in brain iron changes in
svMCI. QSM can accurately measure the susceptibilities of iron
distribution in the deep brain nuclei and basal ganglia (Wang
and Liu, 2015). Iron metabolism in normal aging, movement, and
neurodegenerative disorders is an active area of research by QSM
(Acosta-Cabronero et al., 2013; He et al., 2015; Darki et al., 2016;
Moon et al., 2016). However, increased iron accumulation has
rarely been demonstrated through QSM in svMCI or other form
of SVD. Using high-resolution T2∗-weighted imaging, a study
revealed increased diffuse iron accumulation in the putamen and
caudate nucleus of patients with small-vessel disease cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy (CADASIL). This result supported that
SVD contributes to increased iron accumulation in the general
population (Liem et al., 2012). Brain iron deposition also could be
a biomarker of SVaD. It has been demonstrated by SWI that SVaD
patients had abnormal iron deposition in widely cortical areas
including hippocampus, which was related to neuropsychological
scores (Liu et al., 2015a). Another study assessed iron deposition
automatically following manual editing found iron accumulation
might be an indicator of SVD that predispose to white matter
damage which affecting the neuronal networks underlying higher
cognitive functioning (Valdes Hernandez et al., 2016). In the
present study, our QSM results showed similar patterns in svMCI.
To our knowledge, the current results constitute the first attempt
to estimate QSM alterations in the brains of svMCI patients.
We found that the most striking deep gray matter feature is a
marked increase in magnetic susceptibility in the putamen and
hippocampus. Given that svMCI is a prodromal stage of SVaD,
our finding may provide a potential biomarker for early diagnosis
before clinical deterioration begins.
Our results indicated that the susceptibility value in the
hippocampus was negatively correlated with memory z-score
in the svMCI brain. Several neuroimaging studies have found
hippocampal atrophy in svMCI or SVaD (Kim et al., 2014, 2015;
Li et al., 2016). The hippocampus is susceptible to ischemia
and lower blood volume; thus, hippocampal changes may be
attributed to delayed neuronal death caused by chronic ischemia.
Frontiers in Aging Neuroscience | www.frontiersin.org 7 March 2017 | Volume 9 | Article 81
fnagi-09-00081 March 28, 2017 Time: 16:37 # 8
Sun et al. Brain Iron Deposition in svMCI
An animal model of ischemia demonstrated that reducing
cerebral blood flow causes memory and behavioral impairments
and neuronal loss in the hippocampus (Roman et al., 2002).
The hippocampus plays important roles in multiple memory
systems (Schwarting and Busse, 2016). Given that the svMCI
patients had a worse memory z-score— which reflects memory
processing (i.e., auditory information retrieval processing,
visuoperception, and short-term visual memory)— than the
controls, we assume that the poor memory output of svMCI
patients may be partially attributed to iron accumulation in
the hippocampus. On the other hand, the susceptibility value
of the hippocampus is positively correlated with the language
z-score, which reflects language function. We found that
svMCI patients exhibited more severe cognitive impairments
in attention-executive and memory functions than in language
function. However, the reason for the positive correlation
between iron accumulation in the hippocampus and language
z-score remains unclear. The speech-dominant hemisphere’s
hippocampus plays a key role in language function, particularly
naming. Naming function and functional MRI activation in the
left hippocampus were significantly correlated (Bonelli et al.,
2012). Thus, it is possible that altered iron distribution affects
cognitive function. Further studies, however, are needed to
clarify these issues. The susceptibility value in the putamen
and attention-executive z-score were inversely related in
svMCI subjects. Recent studies have shown that as part of
the striatum, the putamen mainly regulates movements and
influences various types of learning. The putamen is also
involved in the emergence of dementia in neurodegenerative
disorders, indicating its effect on cognitive impairment (de
Jong et al., 2008). Putamenal lesions might cause behavioral
and cognitive changes. Putamenal hemorrhages could disrupt
dorsolateral-striato-pallido-thalamic circuits and cause executive
dysfunction (Kokubo et al., 2015). The putamen also plays
an important role in basal ganglia-thalamic circuits that are
involved in attentive processing (Tortorella et al., 2013). The
present study is in line with these results. Hence, our findings
may further confirm the role of the putamen in cognitive
function, especially in attention-executive function. Alterations
in putamen susceptibility values and its relationships with
the z-score suggest that putamen could be linked to the
pathophysiology of svMCI and indicate the clinical relevance as a
biomarker.
This study has several limitations. First, we did not include
a control group of healthy elderly subjects. Second, the MRI
and neuropsychological test were not performed simultaneously.
Third, the relatively small number of patients limited our
cross-sectional study. Thus, a longitudinal study that follows
large cohorts of svMCI patients throughout their conversion
to SVaD is crucial to investigate the dynamic course of iron
deposition and confirm the physiopathological processes of
SVaD. Fourth, as with all in vivo MRI studies of svMCI, our
study was limited by the lack of pathologically confirmed patients,
although we diagnosed the patients with both comprehensive
neuropsychological assessments and MRI. Finally, the precise
mechanisms that led to higher iron concentration in svMCI
patients still remain unclear and should be further investigated.
CONCLUSION
We found that QSM is a feasible technique for measuring
iron deposition in the subcortical nuclei. Iron was mainly
deposited in the bilateral hippocampus and right putamen of
the svMCI group. The relationship between the susceptibility
value in the putamen and attention-executive z-score, and
between the susceptibility value in the hippocampus and
memory z-score, implicate the putamen and hippocampus in
the pathophysiology of svMCI. Furthermore, these relationships
could explain the cognitive disturbances seen in the svMCI group.
Our results indicated that the association between increased
brain iron-burden and neurocognitive dysfunction was caused by
svMCI. Moreover, our results provide evidence that accumulated
subcortical iron is a biomarker for the pathophysiological
mechanism of neural and cognitive decline in the evolution of
svMCI.
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